Bibliographie (2362)
Covid-19: Middle aged women face greater risk of debilitating long term symptoms
lundi, 29 mars 2021 03:28 Écrit par Zouhair SouissiCovid-19: Middle aged women face greater risk of debilitating long term symptoms – The BMJ Linked Opinion: The stigma is real for people living with long covid – The BMJ Opinion
The post Covid-19: Middle aged women face greater risk of debilitating long term symptoms appeared first on Links Medicus.
Another study indicates SARS-CoV-2 variant B.1.351, but not variant B.1.1.7, has partial resistance to neutralizing antibodies generated by natural infection or mRNA vaccination
lundi, 29 mars 2021 03:28 Écrit par Zouhair SouissiSensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies – Nature Medicine Commentaries on Twitter Now a peer-reviewed pub in a top journal, this elegant study clearly shows that variant B.1.351 isn't stopped by antibodies from prior infection or the Pfizer vax. We'll have revised vaccines, but we don't yet. Please behave […]
The post Another study indicates SARS-CoV-2 variant B.1.351, but not variant B.1.1.7, has partial resistance to neutralizing antibodies generated by natural infection or mRNA vaccination appeared first on Links Medicus.
Cochrane Library Editorial: Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID‐19
lundi, 29 mars 2021 03:28 Écrit par Zouhair SouissiContested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID‐19 – Cochrane Library Commentary and Infographic: Is chloroquine or hydroxychloroquine useful in treating people with COVID-19, or in preventing infection in people who have been exposed to the virus? – Cochrane Library Original review: Chloroquine or hydroxychloroquine for prevention and treatment […]
The post Cochrane Library Editorial: Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID‐19 appeared first on Links Medicus.
Covid: The London bus trip that saved maybe a million lives (about the creation of the RECOVERY Trial)
vendredi, 26 mars 2021 12:27 Écrit par Zouhair SouissiCovid: The London bus trip that saved maybe a million lives – BBC Related: Covid-19: The Inside Story of the RECOVERY Trial Commentary on Twitter Very cool story by @JamesTGallagher about a convo on a London bus that led to the creation of the RECOVERY trial, which has been a shining (& too rare) […]
The post Covid: The London bus trip that saved maybe a million lives (about the creation of the RECOVERY Trial) appeared first on Links Medicus.
Pushing back against U.S. health officials, AstraZeneca says new analysis confirms efficacy of its Covid-19 vaccine
vendredi, 26 mars 2021 12:27 Écrit par Zouhair SouissiPushing back against U.S. health officials, AstraZeneca says new analysis confirms efficacy of its Covid-19 vaccine – STAT News release: AZD1222 US Phase III primary analysis confirms safety and efficacy – AstraZeneca See also: Latest results put Oxford–AstraZeneca COVID vaccine back on track – Nature AND AstraZeneca’s absurd and unprecedented dispute with regulators, explained – […]
The post Pushing back against U.S. health officials, AstraZeneca says new analysis confirms efficacy of its Covid-19 vaccine appeared first on Links Medicus.
Another study shows increased transmissibility of SARS-CoV-2 lineage B.1.1.7 with a 50% to 100% higher reproduction number
vendredi, 26 mars 2021 12:27 Écrit par Zouhair SouissiAssessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England – Nature Related: Study confirms higher transmissibility of SARS-CoV-2 lineage B.1.1.7 (study and commentary) Commentary on Twitter Just published @nature: Transmissibility of the B.1.1.7 (UK) variant https://t.co/dsMge8bB83 "A substantial transmission advantage with a 50 to 100% higher reproduction number"Secondary attack rates were 30-40% higher than ancestral […]
The post Another study shows increased transmissibility of SARS-CoV-2 lineage B.1.1.7 with a 50% to 100% higher reproduction number appeared first on Links Medicus.
Practice Pointer: Remote management of Covid-19 using home pulse oximetry and virtual ward support
vendredi, 26 mars 2021 12:27 Écrit par Zouhair SouissiRemote management of covid-19 using home pulse oximetry and virtual ward support – The BMJ Related: Virtual clinics are reassuring but sometimes daunting – The BMJ Commentary on Twitter Our new BMJ paper – home oximetry and virtual wards (how to do it, when to do it, tips and caveats). @drmknight @mattinadakim @CeciliaVindrola Naomi […]
The post Practice Pointer: Remote management of Covid-19 using home pulse oximetry and virtual ward support appeared first on Links Medicus.
RCT: Similar number of days free of respiratory support with helmet noninvasive ventilation vs. high-flow nasal oxygen in patients with COVID-19 and moderate to severe hypoxemic respiratory failure
vendredi, 26 mars 2021 12:27 Écrit par Zouhair SouissiEffect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial – JAMA (free for a limited period) Editorial: Respiratory Support During the COVID-19 Pandemic: Is It Time to Consider Using a Helmet? Video: Helmet […]
The post RCT: Similar number of days free of respiratory support with helmet noninvasive ventilation vs. high-flow nasal oxygen in patients with COVID-19 and moderate to severe hypoxemic respiratory failure appeared first on Links Medicus.
Perspective | New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
jeudi, 25 mars 2021 12:05 Écrit par Zouhair SouissiNew SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications – New England Journal of Medicine
The post Perspective | New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications appeared first on Links Medicus.
![[Press release – not published yet] Trial of multi drug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior](/media/k2/items/cache/f59e5e3530c2c45e61d5a0c945f954cb_S.jpg)
[Press release – not published yet] Trial of multi drug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior
jeudi, 25 mars 2021 12:05 Écrit par Zouhair SouissiTrial of multi drug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior – Médecins Sans Frontières Commentary on Twitter Promising news improving treatment #MDR #TB https://t.co/Lxjb7LBofy Translating findings to available drugs & diagnostics back it up will be key pic.twitter.com/YGp8d9ixww — Michael Marks (@dr_michaelmarks) March 24, 2021
The post [Press release – not published yet] Trial of multi drug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior appeared first on Links Medicus.
